Organogenesis Holdings Inc.
ORGO
$5.01
-$0.01-0.20%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 30.66% | -22.62% | -21.17% | 27.10% | 6.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.98% | -22.44% | -21.17% | 27.10% | 6.12% |
| Cost of Revenue | 35.29% | -5.37% | -17.33% | 11.82% | 3.90% |
| Gross Profit | 29.68% | -27.38% | -22.53% | 33.00% | 6.82% |
| SG&A Expenses | 10.35% | -3.57% | 0.26% | 24.20% | 11.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.14% | -7.82% | -6.11% | 17.61% | 8.52% |
| Operating Income | 255.09% | -221.56% | -423.86% | 1,474.58% | -23.36% |
| Income Before Tax | 263.39% | 18.61% | -493.67% | 670.88% | -23.75% |
| Income Tax Expenses | 93.75% | -197.56% | -209.41% | 310.10% | -245.59% |
| Earnings from Continuing Operations | 74.90% | 44.89% | -797.29% | 1,450.88% | 289.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 74.90% | 44.89% | -797.29% | 1,450.88% | 289.36% |
| EBIT | 255.09% | -221.56% | -423.86% | 1,474.58% | -23.36% |
| EBITDA | 153.95% | -147.72% | -13,234.71% | 201.75% | -10.67% |
| EPS Basic | 23.12% | 50.78% | -975.47% | 1,153.49% | 285.89% |
| Normalized Basic EPS | 304.73% | -227.76% | -361.65% | 8,133.33% | -25.27% |
| EPS Diluted | 22.22% | 50.23% | -755.00% | 1,032.56% | 350.00% |
| Normalized Diluted EPS | 296.69% | -227.76% | -361.65% | 7,983.33% | -24.86% |
| Average Basic Shares Outstanding | -4.29% | -4.31% | -4.22% | -0.95% | 0.96% |
| Average Diluted Shares Outstanding | -2.30% | -4.31% | -4.22% | 0.23% | 0.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |